← Back to all trials
Not Yet Recruiting
NCT07731425
Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival
Conditions: Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 3000
Sponsor: London School of Economics and Political Science
Location: Harvard Medical School and Harvard Pilgrim Health Care Institute Boston Massachusetts
Summary
This study of current or former cancer patients will evaluate whether communicating data on overall survival data in addition to information on progression-free improves the accuracy of cancer patients' expectations about the survival benefits of new cancer drugs
Eligibility Criteria
Inclusion Criteria:
* US adults with a current or former cancer diagnosis (excluding nonmelanoma skin cancer)
* US adults 18 years of age and older, fluent in English, and residing in the United States.
Exclusion Criteria:
* Adults who do not have a former cancer diagnosis or who were diagnosed with nonmelanoma skin cancer; adults who complete the survey in under 150 seconds, and who do not meet the other inclusion criteria.
Source: ClinicalTrials.gov (NCT07731425). StuddyBuddy aggregates publicly available trial information.
